HLI Short Sellers Step Back Ahead of Earnings

Houlihan Lokey enters today's earnings report with short sellers retreating at a notably faster pace than most of its boutique advisory peers. Short interest has fallen to 3.7% of the free float, down nearly 15% over the past week, a move that is 1.5 standard deviations below the stock's typical weekly change. Among close peers, Moelis (MC) and PJT Partners (PJT) both carry heavier short positioning on a relative basis, making HLI one of the less crowded names in the group heading into results.

That retreat has arrived alongside a sharp price recovery. HLI gained 7% over the past week, roughly double the median gain of 3.5% across its nearest peers. Evercore was the outlier to the upside, rising more than 16% on the week, while Lazard and Stifel lagged considerably. The borrow market reinforces the picture of easing pressure: availability is extremely loose at 2,501%, meaning roughly 25 shares are available to borrow for every one currently lent out, and the cost to borrow has dropped 26% over the past week to just 0.31%. There is no meaningful squeeze dynamic here.

Options positioning leans constructively. The put/call ratio has dropped to 0.27, more than one standard deviation below its 20-day average of 0.29, a reading that points to call demand outpacing put hedging into the print. That said, the 52-week range for the ratio runs from 0.05 to 2.44, so the current level still sits well within normal territory rather than at any extreme.

The analyst picture is mixed but tilts positive. Citizens upgraded HLI to Market Outperform with a $175 target on October 9, while Morgan Stanley trimmed its target to $165 from $177 but held its Overweight rating. UBS raised its Neutral target to $154 from $147. The consensus mean target is $155, roughly 13% above Wednesday's close of $137.38. The previous quarter's print produced an 11.8% single-day drop, and the stock has yet to recover all of that ground, which likely explains some of the caution embedded in targets below where the shares traded a few months ago. Wikipedia attention toward HLI has spiked to a z-score of 2.6 against its own 90-day history, the highest retail attention reading ORTEX's alt data layer records for the stock in recent months, suggesting the print is drawing more eyes than usual.

The controlling ownership structure is worth noting. Two voting trusts, HL Voting Trust and A&R Voting Trust, together disclose stakes of roughly 22.9% and 22.5% of shares respectively under Schedule 13D filings, giving the founding partners significant combined control. BlackRock is the largest external institutional holder at around 7.5% of shares. Capital Research added nearly 795,000 shares in the most recent quarter, and Neuberger Berman added close to 382,000, suggesting active accumulation from institutional investors at lower prices. On the insider side, CFO J. Lindsey Alley made an open-market purchase of 4,020 shares at $124.52 in August, a direct discretionary buy that is more informative than the various stock grants and option exercises also on the register.

Today's print will test whether the recovery in deal activity that peers like Evercore appear to be pricing in has reached Houlihan Lokey's advisory and restructuring books, and whether management's commentary on M&A pipelines justifies the gap between the current share price and where most analysts have set their targets.